Shire signs $2.1bn loan with core banking group
UK based bio-pharmaceutical company Shire signed a $2.1bn loan last week. The five year loan has two one-year extension options and comprises multi-currency revolving and swingline facilities.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts